We provide you with 20 years of free, institutional-grade data for AMGN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AMGN. Explore the full financial landscape of AMGN stock.
Reported Date | CIK | Ticker | Type | |
---|---|---|---|---|
2025-08-06 | 318154 | AMGN | 10-Q | Url |
2025-05-02 | 318154 | AMGN | 10-Q | Url |
2025-02-14 | 318154 | AMGN | 10-K | Url |
2024-10-31 | 318154 | AMGN | 10-Q | Url |
2024-08-07 | 318154 | AMGN | 10-Q | Url |
2024-05-03 | 318154 | AMGN | 10-Q | Url |
2024-02-14 | 318154 | AMGN | 10-K | Url |
2023-10-31 | 318154 | AMGN | 10-Q | Url |
2023-08-04 | 318154 | AMGN | 10-Q | Url |
2023-04-28 | 318154 | AMGN | 10-Q | Url |
2023-02-09 | 318154 | AMGN | 10-K | Url |
2022-11-04 | 318154 | AMGN | 10-Q | Url |
2022-08-05 | 318154 | AMGN | 10-Q | Url |
2022-04-28 | 318154 | AMGN | 10-Q | Url |
2022-02-16 | 318154 | AMGN | 10-K | Url |
2021-11-03 | 318154 | AMGN | 10-Q | Url |
2021-08-04 | 318154 | AMGN | 10-Q | Url |
2021-04-28 | 318154 | AMGN | 10-Q | Url |
2021-02-09 | 318154 | AMGN | 10-K | Url |
2020-10-29 | 318154 | AMGN | 10-Q | Url |
2020-07-29 | 318154 | AMGN | 10-Q | Url |
2020-05-01 | 318154 | AMGN | 10-Q | Url |
2020-02-12 | 318154 | AMGN | 10-K | Url |
2019-10-30 | 318154 | AMGN | 10-Q | Url |
2019-07-31 | 318154 | AMGN | 10-Q | Url |
2019-05-01 | 318154 | AMGN | 10-Q | Url |
2019-02-13 | 318154 | AMGN | 10-K | Url |
2018-10-31 | 318154 | AMGN | 10-Q | Url |
2018-07-27 | 318154 | AMGN | 10-Q | Url |
2018-04-25 | 318154 | AMGN | 10-Q | Url |
2018-02-13 | 318154 | AMGN | 10-K | Url |
2017-10-26 | 318154 | AMGN | 10-Q | Url |
2017-07-26 | 318154 | AMGN | 10-Q | Url |
2017-04-27 | 318154 | AMGN | 10-Q | Url |
2017-02-14 | 318154 | AMGN | 10-K | Url |
2016-10-28 | 318154 | AMGN | 10-Q | Url |
2016-07-29 | 318154 | AMGN | 10-Q | Url |
2016-05-02 | 318154 | AMGN | 10-Q | Url |
2016-02-16 | 318154 | AMGN | 10-K | Url |
2015-11-02 | 318154 | AMGN | 10-Q | Url |
2015-08-05 | 318154 | AMGN | 10-Q | Url |
2015-04-27 | 318154 | AMGN | 10-Q | Url |
2015-02-19 | 318154 | AMGN | 10-K | Url |
2014-10-29 | 318154 | AMGN | 10-Q | Url |
2014-08-05 | 318154 | AMGN | 10-Q | Url |
2014-04-30 | 318154 | AMGN | 10-Q | Url |
2014-02-24 | 318154 | AMGN | 10-K | Url |
2013-10-29 | 318154 | AMGN | 10-Q | Url |
2013-08-06 | 318154 | AMGN | 10-Q | Url |
2013-05-03 | 318154 | AMGN | 10-Q | Url |
2013-02-27 | 318154 | AMGN | 10-K | Url |
2012-11-06 | 318154 | AMGN | 10-Q | Url |
2012-08-08 | 318154 | AMGN | 10-Q | Url |
2012-05-08 | 318154 | AMGN | 10-Q | Url |
2012-02-29 | 318154 | AMGN | 10-K | Url |
2011-11-04 | 318154 | AMGN | 10-Q | Url |
2011-08-08 | 318154 | AMGN | 10-Q | Url |
2011-05-10 | 318154 | AMGN | 10-Q | Url |
2011-02-25 | 318154 | AMGN | 10-K | Url |
2010-11-08 | 318154 | AMGN | 10-Q | Url |
2010-08-09 | 318154 | AMGN | 10-Q | Url |
2010-05-07 | 318154 | AMGN | 10-Q | Url |
2010-03-01 | 318154 | AMGN | 10-K | Url |
2009-11-06 | 318154 | AMGN | 10-Q | Url |
2009-08-10 | 318154 | AMGN | 10-Q | Url |
2009-05-11 | 318154 | AMGN | 10-Q | Url |
2009-02-27 | 318154 | AMGN | 10-K | Url |
2008-11-07 | 318154 | AMGN | 10-Q | Url |
2008-08-08 | 318154 | AMGN | 10-Q | Url |
2008-05-12 | 318154 | AMGN | 10-Q | Url |
Amgen Inc(NASDAQ:AMGN)

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and...
Website: http://www.amgen.com
Founded: 1980
Full Time Employees: 23,400
Sector: Healthcare
Industry: Drug Manufacturers-General
The information provided in this report about AMGN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.